Comparison of ARISCAT Score and Post-operative Pulmonary Complication Rate in Percutaneous Nephrolithotomy
1 other identifier
observational
50
1 country
1
Brief Summary
Postoperative pulmonary complications are relatively common in all age groups and are closely related to increased costs, morbidity and mortality in the postoperative period. In recent years, various risk indices have been developed for preoperative evaluation to predict postoperative pulmonary complications, such as the American Society of Anaesthesiologists Physical Status Classification (ASA), the Assessment of Respiratory Risk in Surgical Patients in Catalonia (ARISCAT). The ARISCAT score has demonstrated promising results in identifying patients at higher risk for pulmonary complications. The ARISCAT risk index is derived from multiple variables, including age, oxygen saturation, previous respiratory tract infections, anaemia, abdominal or thoracic surgery, operative time, and emergency surgery. The ARISCAT risk index is used to predict respiratory failure, bronchospasm, respiratory tract infections, atelectasis, pneumothorax, pleural effusion, and aspiration pneumonia. Percutaneous nephrolithotomy (PNL) is a type of operation performed endoscopically in a prone position in cases of kidney stones that cannot be broken by extracorporeal shockwave lithotripsy (ESWL) and/or cannot be removed by ureterocystoscopy. The prone position is one of the positions that limits lung capacity and respiratory function. The objective of this study was to assess the relationship between the ARISCAT score in patients undergoing PNL and the occurrence of pulmonary complications in the postoperative period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedFirst Submitted
Initial submission to the registry
May 10, 2024
CompletedFirst Posted
Study publicly available on registry
May 16, 2024
CompletedMay 16, 2024
May 1, 2024
8 months
May 10, 2024
May 14, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
rate of pulmonary complication
rate of pulmonary complication such as respiratory failure, bronchospasm, atelectasis, pneumothorax, pleural effusion, or aspiration pneumonia.
The postoperative period in the first 24 hours
rate of lung infection
rate of pneumonia (bacterial or virutic)
The postoperative period in the first 72 hours
Study Arms (1)
Patients who had undergone Percutaneous Nephrolithotomy
Eligibility Criteria
The study included 50 ASA I-III patients aged between 18 and 80 years who were about to undergo percutaneous nephrolithotomy.
You may qualify if:
- American Society of Anesthesiologists (ASA) I-III patients
- Patients who undergone of Percutaneous Nephrolithotomy procedure
You may not qualify if:
- Patients with any liver and/or kidney failure
- Obese patients (body mass index (BMI) 30 and above)
- Trauma patients
- Cancer patients
- American Society of Anesthesiologists (ASA) IV patients
- Cardiac arrhythmia, implanted pacemakers
- A history of chronic pain
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Health Science Turkey Sanliurfa Mehmet Akif Inan Training and Research Hospital
Sanliurfa, 63050, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant professor
Study Record Dates
First Submitted
May 10, 2024
First Posted
May 16, 2024
Study Start
August 31, 2023
Primary Completion
May 1, 2024
Study Completion
May 1, 2024
Last Updated
May 16, 2024
Record last verified: 2024-05